QL
AXSM icon

Quarry LP’s Axsome Therapeutics AXSM Stock Holding History

Quarry LP’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$490K Sell
2,000
-3,000
-60% -$651K 0.04% 168
2026
Q1 		$845K Buy
5,000
+4,980
+24,900% +$860K 0.15% 109
2025
Q4 		$3.65K Sell
20
-1,230
-98% -$172K ﹤0.01% 1783
2025
Q3 		$152K Sell
1,250
-1,250
-50% -$141K 0.03% 427
2025
Q2 		$261K Buy
2,500
+1,100
+79% +$116K 0.06% 304
2025
Q1 		$163K Buy
1,400
+650
+87% +$74.1K 0.04% 346
2024
Q4 		$63.5K Sell
750
-1,250
-63% -$115K 0.01% 635
2024
Q3 		$180K Sell
2,000
-1,200
-38% -$105K 0.05% 263
2024
Q2 		$258K Buy
3,200
+1,400
+78% +$104K 0.07% 129
2024
Q1 		$144K Buy
+1,800
New +$151K 0.03% 201
2023
Q4 		– Sell
-1,745
Closed -$122K – 1391
2023
Q3 		$122K Buy
+1,745
New +$130K 0.03% 182

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quarry LP's AXSM Position: Q2 2026 in Review

Quarry LP reduced its Axsome Therapeutics (AXSM) stake by 60% in Q2 2026, selling an estimated $651K and leaving 2,000 shares worth $490K. The position accounts for 0.04% of the portfolio, ranked #168.

Quarry LP first reported a position in AXSM in Q3 2023 and has held it in 11 quarters since. The position peaked at $845K in Q1 2026. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Quarry LP held 2,000 shares of Axsome Therapeutics worth $490K as of Q2 2026.
  • Quarry LP sold 3,000 Axsome Therapeutics shares in Q2 2026, an estimated $651K.
  • Axsome Therapeutics made up 0.04% of Quarry LP's portfolio in Q2 2026, its #168 holding.
  • Quarry LP first reported a position in Axsome Therapeutics in Q3 2023 and has held it in 11 quarters since.
  • Quarry LP's Axsome Therapeutics position peaked at $845K in Q1 2026.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.